Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0580
D

Failure to Notify Responsible Party of New Medication Prior to Administration

South Bend, Indiana Survey Completed on 06-19-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

The facility failed to ensure timely notification of a resident's responsible party regarding the initiation of a new medication, Ativan, and the associated risks and benefits prior to its administration. Interviews with the Social Service Director at a local dialysis center revealed that the resident, who had diagnoses including Alzheimer's disease, vascular dementia, chronic kidney disease, and adjustment disorder with anxiety, was prescribed Ativan to be administered before dialysis sessions. The dialysis center staff observed the resident arriving lethargic and requested discontinuation of the medication after several weeks. Documentation showed that the responsible party was not informed about the new medication at the time of its initial administration, and the addition of Ativan was not discussed during a care plan meeting, despite a note indicating that medications were reviewed. Further interviews with the Memory Care Director, Assistant Director of Nursing, and Director of Nursing confirmed that the responsible party was not notified about the prescription of Ativan prior to its administration. The only documentation of notification was a care plan note stating that medications were reviewed, but it did not specify that Ativan had been discussed. The facility's policy required that all changes in a resident's condition, including new medications, be communicated to the responsible party prior to the end of the assigned shift, with documentation of the notification and response. This policy was not followed in this instance, resulting in a deficiency.

An unhandled error has occurred. Reload 🗙